Latest Advisories

  • FDA Advisory No. 2014-064 || Public Health Warning Against the Use of Unregistered Product Leisure Burn Body Fat Orange Juice

    Read more...
  • FDA Advisory No. 2014-063 || Public Health Warning Against the Use of Unregistered Product

    Read more...
  • FDA Advisory No. 2014-062 || Voluntary Withdrawal of One Batch of NAN Pro Two Infant Formula with Lot Identification No. 414901898A

    Read more...
  • FDA Advisory No. 2014-061 || Certificates of General Acceptability or Safety

    Read more...
  • FDA Advisory No. 2014-060-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong “CEFUROXIME 125 MG PER 5 ML GRANULES FOR ORAL SUSPENSION (CEFX)”

    Read more...

 During the 51st Anniversary celebration on June 23, 2014, FDA Director General Dr. Kenneth Y. Hartigan-Go, and CHD-XI Director Abdullah B. Dumama signed a Memorandum of Agreement, which would allow the FDA to use a portion of the land at the CHD-XI Office in Davao City to build the P30M FDA Regulatory Field Office in Mindanao.

The momentous event was witnessed by the FDA Deputy Director General, Dr. Ariel Valencia and the OIC of the FDA Lega Support Services Center, Atty. Donna Sanchez, together with other member of the FDA Management Team and representatives of the Cebu and Davao Satellite Laboratories.

 Assistant Secretary Romulo A. Busuego, the DOH Mindanao Cluster Head, sent his message of full support to the FDA-CHD-XI Project in Davao City. The eventual presence of the FDA, as health regulatory agency, in Mindanao would be help ensure that the people, especially the uderprivileged, have adequate and equitable access to health products, facilities and services, and will help support the government's efforts to sustained long-term economic growth and poverty reduction, as well as peace and order in the region.

Announcement

  • To All Concerned:

    This is to inform you that FDA conducted system upgrade last July 28 - 30 2014.

    Happy to inform you that the system is now fully operational.

    Thank You for bearing with us.

     

  • IMS ADVISORY || Slow or Intermittent Internet Connection

     

    Please be informed that due to typhoon Glenda, the DOH Fiber optic (FOC) links (last mile) from two DOH Internet Service Providers (ISPs) which use Bell Telecommunication and Radius are down since 8:00 am of Wednesday, July 16, 2014. Currently, only our third ISP operating at 50 mbps only. The Technical staff from IMS staff are continuously coordinating with the Engineers of the two ISPs for immediate restoration of the said links as actual replacement only started yesterday

    For this reason, DOH internet connection via this links including VOIP calls to all regional offices and hospitals and DOH domain name (doh.gov.ph) are greatly affected

    For any concerns and assistance you may need, kindly call Mr. Joel R. Arias, Mr. Richard T. Regina or Mr. Ronald T. Marcellana at extension no. 1925 and 1934

  • FDA Announcement

    Subject : Cancellation of CDRR QPIRA Training Schedules on 5 & 6 June, 2014

    TO : All Concerned Stakeholders

    The Qualified Person in Industry Regulatory Affairs (QPIRA) Training for Vaccines and Biological Products as well as Veterinary Product scheduled on June 5 & 6, 2014, Respectively, will be cancelled due to short number of pre-registered participants as per FDA Circular No. 2014-001, pre-registered participant shall be re-scheduled in an event of cancellation. The said QPIRA Trainings will be rescheduled on September 4 & 5, 2014

    For question and clarifications, please contact the FDA Academy through telephone no. 857-1976

    Thank you for support and consideration

  • Announcement

    Automatic Renewal Applications submitted from December 2013 - onwards

    All pharmaceutical companies with Automatic Renewal (AR) applications submitted from December 2013 onwards are requested to submit the revised Declaration page of the Application Form posted at the FDA website in soft and hard copies to comply with the requirements of AR based on Bureau Circular No. 005-2006.

    Submission may be coursed through the Center for Drug Regulation and Research (CDRR) c/o Ms. Liza Pajarillo and/or Ms. Raquel Dime from Mondays to Fridays, 8 am to 12 noon. Please quote the fourteen (14) digit Document Tracking Number issued for the AR application.

    All Marketing Authorization Holders with applications submitted on November 2013 and which were disapproved due to non-submission of the complete Declaration page must file a request for reconsideration and provide the printed and electronic copies of the revised Declaration page duly notarized. Such request should be filed at the PAIR Unit (over the counter) quoting the old Document Tracking Number issued.

    Thank you for your cooperation.

    Download Attachment to continue reading

     

    Read more...

Videos

  • FDA Public Assistance Information and Receiving (PAIR) Video Tutorial

    A step by step guide to filing an application for a License to Operate or a Certificate of Product Registration.
    By: Nicole Melanie Molera

  • Dr. Kenneth Hartigan-Go on Responsible Pharmaceutical Manufacturing by Interphil

    Dr. Kenneth Hartigan-Go talks about importance of CGMP in manufacturing pharmaceutical products, bioequivalence, importance of adverse drug monitoring, and ethical marketing communications.

Share Us on

Submit to FacebookSubmit to Google BookmarksSubmit to Twitter